Part D plans generally include drugs commonly used by dual-eligible enrollees: 2023
- Collection:
- Health Policy and Services Research
- Series Title(s):
- Data snapshot (United States. Department of Health and Human Services. Office of Inspector General)
- Contributor(s):
- United States. Department of Health and Human Services. Office of Inspector General. Office of Evaluation and Inspections, issuing body.
- Publication:
- Washington, D.C. : U.S. Department of Health and Human Services, Office of Inspector General, July 2023
- Language(s):
- English
- Format:
- Text
- Subject(s):
- Dual MEDICAID MEDICARE Eligibility Formularies as Topic Government Regulation Medicare Part D Prescription Drugs United States
- Genre(s):
- Technical Report
- Abstract:
- Why OIG Did This Review. For dual-eligible enrollees - that is, people enrolled in both Medicare and Medicaid - access to prescription drugs is particularly important. Overall, they have very low incomes and - because they are more likely to be in poorer health than other people enrolled in Medicare - tend to use more Medicare services. Because Medicare prescription drug coverage is an important tool for ensuring access to prescription drugs, Congress mandated that OIG study whether Part D formularies cover prescription drugs commonly used by dual-eligible enrollees. What OIG Did. For this report, we determined whether the 445 unique formularies used by the 5,619 Part D plans operating in 2023 cover 195 of the 200 drugs most commonly used by dual-eligible enrollees. See the methodology for more information about how we determined the most commonly used drugs. This is OIG’s thirteenth annually mandated report examining dual-eligible enrollees’ access to drugs under Medicare Part D.
- Copyright:
- The National Library of Medicine believes this item to be in the public domain. (More information)
- Extent:
- 1 online resource (1 PDF file (6 pages))
- Illustrations:
- Illustrations
- NLM Unique ID:
- 9918716087906676 (See catalog record)
- Permanent Link:
- http://resource.nlm.nih.gov/9918716087906676